NASDAQ : APMD
Apnimed, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 16.4 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 682.74M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Apnimed, Inc. (APMD) reported revenue of 115.12M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | 115.12M | 38.47M | 8.01M | 1.00M | |
| Cost of Revenue | 7.02M | 6.69M | 3.37M | ||
| Gross Profit | 108.10M | 31.77M | 4.64M | 1.00M | |
| Selling, General & Admin | 31.85M | 23.49M | 21.50M | 11.31M | 6.63M |
| Research & Development | 40.38M | 62.10M | 97.38M | 37.21M | 20.92M |
| Operating Expenses | 72.23M | 85.59M | 118.88M | 48.52M | 27.55M |
| Operating Income | 35.87M | -53.82M | -114.23M | -48.52M | -26.55M |
| Interest & Investment Income | 1.86M | 1.41M | 5.68M | 5.77M | 472.00K |
| Earnings From Equity Investments | 85.38M | -37.50M | |||
| Other Non Operating Income (Expenses) | 51.01M | -5.65M | -132.00K | ||
| Pretax Income | 170.74M | -58.05M | -108.55M | -80.25M | -26.21M |
| Income Tax Expense | 51.00K | ||||
| Earnings From Continuing Operations | 170.74M | -58.05M | -108.60M | -80.25M | -26.21M |
| Earnings From Discontinued Operations | -7.16M | -70.14M | -2.70M | ||
| Net Income | 163.58M | -128.19M | -111.31M | -80.25M | -26.21M |
| Net Income to Common | 163.58M | -128.19M | -111.31M | -80.25M | -26.21M |
| Shares Outstanding (Basic) | 5.42M | 5.40M | 5.37M | 2.88M | 2.37M |
| Shares Outstanding (Diluted) | 19.11M | 5.40M | 5.37M | 2.88M | 2.37M |
| EPS (Basic) | 30.19 | -23.76 | -20.73 | -27.84 | -11.04 |
| EPS (Diluted) | 8.49 | -23.76 | -20.73 | -27.84 | -11.04 |
| Free Cash Flow | -69.94M | -77.83M | -110.28M | 25.36M | -26.13M |
| Free Cash Flow Per Share | -3.66 | -14.42 | -20.54 | 8.80 | -11.00 |
| Gross Margin | 93.90% | 82.60% | 57.95% | 100.00% | |
| Operating Margin | 31.16% | -139.91% | -1,425.79% | -2,654.80% | |
| Profit Margin | 142.10% | -333.25% | -1,389.23% | -2,620.80% | |
| Free Cash Flow Margin | -60.75% | -202.33% | -1,376.42% | -2,612.90% | |
| EBITDA | 35.90M | -53.79M | -114.21M | -48.52M | |
| EBITDA Margin | 31.18% | -139.84% | |||
| D&A For EBITDA | 27.00K | 27.00K | 23.00K | 1.00K | |
| EBIT | 35.87M | -53.82M | -114.23M | -48.52M | -26.55M |
| EBIT Margin | 31.16% | -139.91% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Cash & Equivalents | 172.80M | 41.89M | 68.35M | 26.55M | 133.83M |
| Short-Term Investments | 147.41M | ||||
| Cash & Short-Term Investments | 172.80M | 41.89M | 68.35M | 173.96M | 133.83M |
| Receivables | 690.00K | 959.00K | 1.11M | ||
| Prepaid Expenses | 292.00K | 665.00K | 349.00K | 210.00K | |
| Other Current Assets | 10.99M | 1.54M | 3.43M | 2.29M | 2.13M |
| Total Current Assets | 184.77M | 45.05M | 73.25M | 176.46M | 135.96M |
| Property, Plant & Equipment | 767.00K | 901.00K | 1.16M | 46.00K | |
| Long-Term Investments | 37.50M | ||||
| Other Long-Term Assets | 9.92M | 26.92M | 34.82M | 31.00K | 31.00K |
| Total Assets | 195.46M | 72.87M | 109.22M | 214.04M | 135.99M |
| Accounts Payable | 6.60M | 1.79M | 3.58M | 4.10M | 940.00K |
| Accrued Expenses | 9.01M | 10.94M | 13.40M | 6.05M | 2.24M |
| Current Portion of Leases | 265.00K | 250.00K | 222.00K | 109.00K | |
| Current Unearned Revenue | 19.53M | 97.81M | 25.00M | 10.00M | |
| Other Current Liabilities | 179.00K | 86.00K | 152.00K | 38.00K | 175.00K |
| Total Current Liabilities | 35.58M | 110.88M | 42.36M | 20.19M | 3.47M |
| Long-Term Debt | 89.64M | 40.65M | |||
| Long-Term Leases | 485.00K | 623.00K | 873.00K | ||
| Long-Term Unearned Revenue | 15.24M | 45.36M | 65.00M | ||
| Other Long-Term Liabilities | 57.12M | 64.36M | 64.36M | ||
| Total Liabilities | 125.70M | 224.51M | 152.95M | 149.54M | 3.47M |
| Common Stock | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K |
| Additional Paid-In Capital | 27.51M | 24.56M | 20.54M | 17.45M | 5.23M |
| Retained Earnings | -203.69M | -397.34M | -269.15M | -157.85M | -77.60M |
| Total Common Equity | -176.18M | -372.78M | -248.62M | -140.39M | -72.37M |
| Shareholders' Equity | 69.76M | -151.64M | -43.73M | 64.50M | 132.52M |
| Total Liabilities & Equity | 195.46M | 72.87M | 109.22M | 214.04M | 135.99M |
| Total Debt | 90.39M | 41.52M | 1.09M | 109.00K | |
| Net Cash (Debt) | 82.42M | 371.00K | 67.25M | 173.96M | 133.72M |
| Net Cash Per Share | 4.31 | 0.07 | 12.52 | 60.35 | 56.31 |
| Filing Date Shares Outstanding | 41.63M | 5.38M | 5.38M | 5.35M | 2.37M |
| Total Common Shares Outstanding | 4.80M | 5.38M | 5.38M | 5.35M | 2.37M |
| Working Capital | 149.19M | -65.82M | 30.89M | 156.28M | 132.49M |
| Book Value Per Share | -36.69 | -69.33 | -46.24 | -26.23 | -30.48 |
| Tangible Book Value | -176.18M | -372.78M | -248.62M | -140.39M | -72.37M |
| Tangible Book Value Per Share | -36.69 | -69.33 | -46.24 | -26.23 | -30.48 |
| Machinery | 23.00K | 23.00K | 23.00K | 23.00K | |
| Leasehold Improvements | 94.00K | 94.00K | 94.00K | 24.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Net Income | 163.58M | -128.19M | -111.31M | -80.25M | -26.21M |
| Depreciation & Amortization | 27.00K | 27.00K | 23.00K | 1.00K | |
| Loss (Gain) on Equity Investments | -85.38M | 37.50M | |||
| Stock-Based Compensation | 4.36M | 3.91M | 3.03M | 1.56M | 987.00K |
| Other Operating Activities | 6.57M | 5.88M | -4.42M | -4.00M | 190.00K |
| Change in Accounts Receivable | 265.00K | 156.00K | -1.11M | ||
| Change in Accounts Payable | -1.36M | -1.80M | -515.00K | 3.16M | 1.24M |
| Change in Unearned Revenue | -108.10M | -19.54M | -4.64M | -1.00M | |
| Change in Other Net Operating Assets | -59.91M | -8.41M | 6.04M | 67.43M | -1.34M |
| Operating Cash Flow | -69.94M | -77.83M | -110.21M | 25.41M | -26.13M |
| Capital Expenditures | -70.00K | -47.00K | |||
| Investment in Securities | 100.00M | 152.03M | -143.31M | ||
| Investing Cash Flow | 99.66M | 151.96M | -143.35M | ||
| Long-Term Debt Issued | 35.00M | ||||
| Net Debt Issued (Repaid) | 83.19M | 35.00M | |||
| Issuance of Common Stock | 140.00K | 115.00K | 51.00K | 10.69M | |
| Other Financing Activities | -4.07M | -243.00K | -27.00K | -500.00K | |
| Financing Cash Flow | 104.25M | 51.37M | 51.00K | 10.66M | 141.75M |
| Foreign Exchange Rate Adjustments | 1.00K | ||||
| Net Cash Flow | 133.98M | -26.46M | 41.80M | -107.28M | 115.62M |
| Free Cash Flow | -69.94M | -77.83M | -110.28M | 25.36M | -26.13M |
| Free Cash Flow Margin | -60.75% | -202.33% | -1,376.42% | -2,612.90% | |
| Free Cash Flow Per Share | -3.66 | -14.42 | -20.54 | 8.80 | -11.00 |
| Levered Free Cash Flow | 40.52M | -48.85M | -12.35M | ||
| Unlevered Free Cash Flow | 40.52M | -48.85M | -12.35M | ||
| Change in Working Capital | -169.10M | -29.59M | -238.00K | 70.59M | -1.10M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Market Capitalization | 682.74M | ||||
| Enterprise Value | 600.33M | ||||
| Debt / Equity Ratio | 1.30 | -0.27 | -0.03 | 0.00 | |
| Net Debt / Equity Ratio | -1.18 | 0.00 | 1.54 | -2.70 | -1.01 |
| Net Debt / EBITDA Ratio | -2.30 | 0.01 | 0.59 | 3.59 | |
| Net Debt / FCF Ratio | 1.18 | 0.01 | 0.61 | -6.86 | 5.12 |
| Asset Turnover | 0.42 | 0.05 | |||
| Quick Ratio | 4.88 | 0.39 | 1.64 | 8.62 | 38.60 |
| Current Ratio | 5.19 | 0.41 | 1.73 | 8.74 | 39.22 |
| Return on Equity (ROE) | -1,045.65% | -81.46% | |||
| Return on Assets (ROA) | -36.94% | -44.17% | -17.33% | ||
| Return on Capital Employed (ROCE) | 22.40% | 141.60% | -170.80% | -25.00% | -20.00% |
| Buyback Yield / Dilution | -562.85% | -0.49% | -86.29% | -21.39% |